GoodRx Holdings, Inc. Selling and Marketing Expense
GoodRx Holdings, Inc. (GDRX) reported Selling and Marketing Expense of $81.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-05
- GoodRx Holdings, Inc. selling and marketing expense for the quarter ending 2026-06-30 was $81.99M, a 3.40% decline year-over-year.
- GoodRx Holdings, Inc. selling and marketing expense for the quarter ending 2026-03-31 was $81.05M, a 4.13% decline year-over-year.
- GoodRx Holdings, Inc. selling and marketing expense for the quarter ending 2025-12-31 was $78.62M, a 16.21% decline year-over-year.
- GoodRx Holdings, Inc. selling and marketing expense for the quarter ending 2025-09-30 was $83.53M, a 7.05% decline year-over-year.
- GoodRx Holdings, Inc. selling and marketing expense for fiscal 2025 was $331.56M, a 9.68% decline from fiscal 2024.
- GoodRx Holdings, Inc. selling and marketing expense for fiscal 2024 was $367.11M, a 7.55% increase from fiscal 2023.
- GoodRx Holdings, Inc. selling and marketing expense for fiscal 2023 was $341.33M, a 4.56% decline from fiscal 2022.
- GoodRx Holdings, Inc. selling and marketing expense for fiscal 2022 was $357.63M, a 3.40% decline from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $81.99M 10-Q · filed 2026-08-05 | $163.04M 10-Q · filed 2026-08-05 | $241.66M derived: sum of 3 quarters · filed 2026-08-05 | $325.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $81.05M 10-Q · filed 2026-05-06 | $159.67M derived: sum of 2 quarters · filed 2026-05-06 | $243.20M derived: sum of 3 quarters · filed 2026-05-06 | $328.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $78.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $162.15M derived: sum of 2 quarters · filed 2026-02-26 | $247.02M derived: sum of 3 quarters · filed 2026-08-05 | $331.56M 10-K · filed 2026-02-26 |
| 2025-09-30 | $83.53M 10-Q · filed 2025-11-04 | $168.40M derived: sum of 2 quarters · filed 2026-08-05 | $252.94M 10-Q · filed 2025-11-04 | $346.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $84.87M 10-Q · filed 2026-08-05 | $169.41M 10-Q · filed 2026-08-05 | $263.24M derived: sum of 3 quarters · filed 2026-08-05 | $353.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $84.54M 10-Q · filed 2026-05-06 | $178.37M derived: sum of 2 quarters · filed 2026-05-06 | $268.24M derived: sum of 3 quarters · filed 2026-05-06 | $361.69M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $93.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $183.70M derived: sum of 2 quarters · filed 2026-02-26 | $277.15M derived: sum of 3 quarters · filed 2026-02-26 | $367.11M 10-K · filed 2026-02-26 |
| 2024-09-30 | $89.87M 10-Q · filed 2025-11-04 | $183.32M derived: sum of 2 quarters · filed 2025-11-04 | $273.29M 10-Q · filed 2025-11-04 | $367.04M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $93.45M 10-Q · filed 2025-08-06 | $183.42M 10-Q · filed 2025-08-06 | $277.17M derived: sum of 3 quarters · filed 2026-02-26 | $368.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $89.96M 10-Q · filed 2025-05-07 | $183.72M derived: sum of 2 quarters · filed 2026-02-26 | $275.33M derived: sum of 3 quarters · filed 2026-02-26 | $352.77M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $93.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $185.37M derived: sum of 2 quarters · filed 2026-02-26 | $262.81M derived: sum of 3 quarters · filed 2026-02-26 | $341.33M 10-K · filed 2026-02-26 |
| 2023-09-30 | $91.61M 10-Q · filed 2024-11-07 | $169.06M derived: sum of 2 quarters · filed 2024-11-07 | $247.58M 10-Q · filed 2024-11-07 | $331.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $77.44M 10-Q · filed 2024-08-08 | $155.96M 10-Q · filed 2024-08-08 | $240.09M derived: sum of 3 quarters · filed 2025-02-27 | $326.31M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $78.52M 10-Q · filed 2024-05-09 | $162.65M derived: sum of 2 quarters · filed 2025-02-27 | $248.87M derived: sum of 3 quarters · filed 2025-02-27 | $343.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $84.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $170.34M derived: sum of 2 quarters · filed 2025-02-27 | $264.68M derived: sum of 3 quarters · filed 2025-02-27 | $357.63M 10-K · filed 2025-02-27 |
| 2022-09-30 | $86.22M 10-Q · filed 2023-11-09 | $180.55M derived: sum of 2 quarters · filed 2023-11-09 | $273.50M 10-Q · filed 2023-11-09 | $379.99M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $94.34M 10-Q · filed 2023-08-09 | $187.29M 10-Q · filed 2023-08-09 | $293.78M derived: sum of 3 quarters · filed 2024-02-29 | $389.43M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $92.95M 10-Q · filed 2023-05-10 | $199.44M derived: sum of 2 quarters · filed 2024-02-29 | $295.09M derived: sum of 3 quarters · filed 2024-02-29 | $383.47M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $106.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $202.14M derived: sum of 2 quarters · filed 2024-02-29 | $290.52M derived: sum of 3 quarters · filed 2024-02-29 | $370.22M 10-K · filed 2024-02-29 |
| 2021-09-30 | $95.65M 10-Q · filed 2022-11-09 | $184.03M derived: sum of 2 quarters · filed 2022-11-09 | $263.73M 10-Q · filed 2022-11-09 | $338.67M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $88.38M 10-Q · filed 2022-08-09 | $168.07M 10-Q · filed 2022-08-09 | $243.01M derived: sum of 3 quarters · filed 2023-03-01 | $308.13M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $79.69M 10-Q · filed 2022-05-10 | $154.63M derived: sum of 2 quarters · filed 2023-03-01 | $219.75M derived: sum of 3 quarters · filed 2023-03-01 | $271.67M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $74.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $140.05M derived: sum of 2 quarters · filed 2023-03-01 | $191.97M derived: sum of 3 quarters · filed 2023-03-01 | $255.13M 10-K · filed 2023-03-01 |
| 2020-09-30 | $65.11M 10-Q · filed 2021-11-12 | $117.03M derived: sum of 2 quarters · filed 2021-11-12 | $180.19M 10-Q · filed 2021-11-12 | $234.52M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $51.92M 10-Q · filed 2021-08-12 | $115.08M 10-Q · filed 2021-08-12 | $169.41M derived: sum of 3 quarters · filed 2022-03-01 | $214.36M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $63.16M 10-Q · filed 2021-05-14 | $117.49M derived: sum of 2 quarters · filed 2022-03-01 | $162.44M derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $54.33M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $99.28M derived: sum of 2 quarters · filed 2022-03-01 | $176.97M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $44.95M 10-Q · filed 2020-11-12 | $122.64M 10-Q · filed 2020-11-12 | ||
| 2018-12-31 | $104.18M 10-K · filed 2021-03-12 |